|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
GE Healthcare GE Healthcare’s Discovery PET/CT Family Grows to Explore Future of Molecular Imaging
GE Healthcare GE Healthcare’s Discovery PET/CT Family Grows to Explore Future of Molecular Imaging
GE Healthcare’s Discovery PET/CT Family Grows to Explore Future of Molecular Imaging
Monday, 15 June 2009 06:41 | 
| Company News - GE Healthcare |
GE Healthcare introduces tailored molecular imaging scanner designed to explore the next frontier of PET/CT
GE Healthcare announces the expansion of its Discovery product line with the Discovery PET/CT 690, a premier molecular imaging scanner designed to explore the development of future clinical applications.
The Discovery PET/CT 690 was built with the academic in mind. The breakthrough scanner allows for improved quantitative accuracy and the reconstruction power needed to explore the potential of PET/CT imaging. The new system leverages the high-speed, high-resolution capabilities of GE’s LightSpeed VCT. Combining the innovative molecular imaging platform with GE’s advanced volume CT and Discovery Dimension console technologies, the Discovery PET/CT 690 provides users with answers to flexibility, time, accuracy and motion.
Flexibility
With a unique detector configuration designed for sensitivity and efficiency, researchers and clinicians have the necessary speed in workflow and protocol flexibility to help explore new frontiers in clinical techniques, drug discovery and motion management.
“We understand the importance of research to the future of healthcare,” said Alex Ganin, chief engineer for GE Healthcare’s Molecular Imaging business. “The Discovery PET/CT 690 scanner, provides researchers the tool they need to take the next step in molecular imaging.”
Time and Accuracy
Time and accuracy of information are critical factors for researchers and clinicians. The Discovery PET/CT 690 includes the exclusive IBM BladeCenter, where users have the ability to reconstruct PET images in minutes instead of hours, potentially improving workflow of detailed studies.
GE’s breakthrough VUE Point FX, the next generation in high-definition reconstruction, provides state of the art performance and unique timing resolution stability. This technology has the potential to improve small lesion detection and image quality when coupled with MotionFree techniques, especially in areas affected by patient motion. Leveraging the coincidence timing capabilities of the Discovery PET/CT 690, VUE Point FX incorporates time-of-flight acquisitions into the VUE Point HD 3D iterative process, providing for image quality improvements in PET/CT scan modes.
With the Discovery PET/CT 690, imagers can take advantage of advanced reconstruction and motion techniques at a routine pace.
“The element of time is important to the future of Molecular Imaging,” said Dr. Ed Coleman from Duke University Medical Center in North Carolina. “With GE’s Discovery PET/CT 690, we are able to incorporate timing resolution in our reconstruction at a clinically relevant pace and advance the level of accuracy in our clinical and research studies.”
Motion
Building on a long history of motion management experience, GE's next generation of MotionFree imaging technologies on the new Discovery PET/CT 690 give clinicians detailed images even in areas of the body subject to movement caused by respiration and cardiac movement. The scanner’s techniques help increase diagnostic confidence and accuracy by addressing motion challenges including artifacts, blurring, and quantification. With the MotionFree suite components, Motion Match to align the PET and CT gated studies, and Motion VUE to improve the reading of motion studies, motion management can be incorporated in research protocols. Users now have the ability to further diagnose and stage with accuracy, plan with precision and monitor with confidence.
The Discovery PET/CT 690 will be on display at the Society of Nuclear Medicine congress in Toronto, Canada June 13-17 at the GE Healthcare Booth 1620. System availability is based on geography.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. For more information about GE Healthcare, visit ebsite at www.gehealthcare.com.
Source: GE Healthcare
GE Healthcare announces the expansion of its Discovery product line with the Discovery PET/CT 690, a premier molecular imaging scanner designed to explore the development of future clinical applications.
The Discovery PET/CT 690 was built with the academic in mind. The breakthrough scanner allows for improved quantitative accuracy and the reconstruction power needed to explore the potential of PET/CT imaging. The new system leverages the high-speed, high-resolution capabilities of GE’s LightSpeed VCT. Combining the innovative molecular imaging platform with GE’s advanced volume CT and Discovery Dimension console technologies, the Discovery PET/CT 690 provides users with answers to flexibility, time, accuracy and motion.
Flexibility
With a unique detector configuration designed for sensitivity and efficiency, researchers and clinicians have the necessary speed in workflow and protocol flexibility to help explore new frontiers in clinical techniques, drug discovery and motion management.
“We understand the importance of research to the future of healthcare,” said Alex Ganin, chief engineer for GE Healthcare’s Molecular Imaging business. “The Discovery PET/CT 690 scanner, provides researchers the tool they need to take the next step in molecular imaging.”
Time and Accuracy
Time and accuracy of information are critical factors for researchers and clinicians. The Discovery PET/CT 690 includes the exclusive IBM BladeCenter, where users have the ability to reconstruct PET images in minutes instead of hours, potentially improving workflow of detailed studies.
GE’s breakthrough VUE Point FX, the next generation in high-definition reconstruction, provides state of the art performance and unique timing resolution stability. This technology has the potential to improve small lesion detection and image quality when coupled with MotionFree techniques, especially in areas affected by patient motion. Leveraging the coincidence timing capabilities of the Discovery PET/CT 690, VUE Point FX incorporates time-of-flight acquisitions into the VUE Point HD 3D iterative process, providing for image quality improvements in PET/CT scan modes.
With the Discovery PET/CT 690, imagers can take advantage of advanced reconstruction and motion techniques at a routine pace.
“The element of time is important to the future of Molecular Imaging,” said Dr. Ed Coleman from Duke University Medical Center in North Carolina. “With GE’s Discovery PET/CT 690, we are able to incorporate timing resolution in our reconstruction at a clinically relevant pace and advance the level of accuracy in our clinical and research studies.”
Motion
Building on a long history of motion management experience, GE's next generation of MotionFree imaging technologies on the new Discovery PET/CT 690 give clinicians detailed images even in areas of the body subject to movement caused by respiration and cardiac movement. The scanner’s techniques help increase diagnostic confidence and accuracy by addressing motion challenges including artifacts, blurring, and quantification. With the MotionFree suite components, Motion Match to align the PET and CT gated studies, and Motion VUE to improve the reading of motion studies, motion management can be incorporated in research protocols. Users now have the ability to further diagnose and stage with accuracy, plan with precision and monitor with confidence.
The Discovery PET/CT 690 will be on display at the Society of Nuclear Medicine congress in Toronto, Canada June 13-17 at the GE Healthcare Booth 1620. System availability is based on geography.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. For more information about GE Healthcare, visit ebsite at www.gehealthcare.com.
Source: GE Healthcare
